As of 2024-12-14, the Relative Valuation of Pangenomic Health Inc (NARA.CN) is - CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.23 CAD, the upside of Pangenomic Health Inc based on Relative Valuation is -.
The range of the Relative Valuation is - CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | P/E |
| 2024-12-10 | -0.25 |
| 2024-12-09 | -0.26 |
| 2024-12-06 | -0.24 |
| 2024-12-05 | -0.15 |
| 2024-12-04 | -0.15 |
| 2024-12-03 | -0.16 |
| 2024-12-02 | -0.13 |
| 2024-11-29 | -0.13 |
| 2024-11-28 | -0.09 |
| 2024-11-27 | -0.16 |
| 2024-11-26 | -0.23 |
| 2024-11-25 | -0.23 |
| 2024-11-22 | -0.27 |
| 2024-11-20 | -0.23 |
| 2024-11-15 | -0.77 |
| 2024-11-14 | -0.71 |
| 2024-11-13 | -0.82 |
| 2024-11-11 | -0.44 |
| 2024-11-05 | -0.25 |
| 2024-10-30 | -0.25 |
| 2024-10-28 | -0.27 |
| 2024-10-25 | -0.22 |
| 2024-10-15 | -0.38 |
| 2024-10-09 | -0.38 |
| 2024-10-04 | -0.38 |
| 2024-10-03 | -0.36 |
| 2024-10-01 | -0.38 |
| 2024-09-30 | -0.36 |
| 2024-09-27 | -0.27 |
| 2024-09-26 | -0.30 |
| 2024-09-20 | -0.36 |
| 2024-09-17 | -0.38 |
| 2024-09-16 | -0.38 |
| 2024-09-13 | -0.38 |